Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotini (Q33416585)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotini |
scientific article |
Statements
1 reference
Dual blockade of epidermal growth factor receptor and insulin-like growth factor receptor-1 signaling in metastatic pancreatic cancer: phase Ib and randomized phase II trial of gemcitabine, erlotinib, and cixutumumab versus gemcitabine plus erlotini (English)
1 reference
Heinz-Josef Lenz
1 reference
Philip A Philip
1 reference
Bryan Goldman
1 reference
Ramesh K Ramanathan
1 reference
Andrew M Lowy
1 reference
Robert P Whitehead
1 reference
Takeru Wakatsuki
1 reference
Syma Iqbal
1 reference
Rakesh Gaur
1 reference
Jacqueline K Benedetti
1 reference
Charles D Blanke
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference